Inositol 1,4,5-trisphosphate receptor (IP 3 R) binding protein released with IP 3 (IRBIT) contributes to various physiological events (electrolyte transport and fluid secretion, mRNA polyadenylation, and the maintenance of genomic integrity) through its interaction with multiple targets. However, little is known about the physiological role of IRBIT in the brain. Here we identified calcium calmodulindependent kinase II alpha (CaMKIIα) as an IRBIT-interacting molecule in the central nervous system. IRBIT binds to and suppresses CaMKIIα kinase activity by inhibiting the binding of calmodulin to CaMKIIα. In addition, we show that mice lacking IRBIT present with elevated catecholamine levels, increased locomotor activity, and social abnormalities. The level of tyrosine hydroxylase (TH) phosphorylation by CaMKIIα, which affects TH activity, was significantly increased in the ventral tegmental area of IRBIT-deficient mice. We concluded that IRBIT suppresses CaMKIIα activity and contributes to catecholamine homeostasis through TH phosphorylation.IRBIT | CaMKIIα | catecholamine | hyperactivity I nositol 1,4,5-trisphosphate receptor (IP 3 R) binding protein released with IP 3 (IRBIT) was originally identified as a molecule that interacts with the intracellular calcium channel, IP 3 R. IRBIT binds to and suppresses IP 3 R activity in the resting state by blocking IP 3 access to IP 3 R (1, 2). Our group and others have reported that IRBIT contributes to electrolyte transport, mRNA processing, and the maintenance of genomic integrity (3-9) through its interaction with multiple targets. However, little is known about the physiological role of IRBIT in the brain, where it is most highly expressed (1).Calcium calmodulin (CaM) dependent kinase II alpha (CaMKIIα) is a Ser/Thr kinase that is abundant in the central nervous system and is activated by the binding of Ca 2+